MedTrace Logo

Determining Disease Activity Biomarkers in Individuals With Polyarteritis Nodosa

NCT00315406 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 107

Last updated 2022-07-12

No results posted yet for this study

Summary

Polyarteritis nodosa (PAN) is a rare immune system disorder that causes swelling and damage to small- and medium-sized blood vessels in the body. In order to properly treat this disease, it is critical that the level of disease activity can be determined over the course of the disease. The purpose of this study is to determine new biological markers, or biomarkers, that may be used to assess the severity of disease in people with PAN.

Conditions

  • Polyarteritis Nodosa

Sponsors & Collaborators

  • Office of Rare Diseases (ORD)

    collaborator NIH

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

    collaborator NIH

  • Rare Diseases Clinical Research Network

    collaborator NETWORK

  • University of Pennsylvania

    lead OTHER

Principal Investigators

  • Peter A. Merkel, MD, MPH · University of Pennsylvania

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00315406 on ClinicalTrials.gov